Annissa Huhn

Annissa Huhn has an extensive work experience in the field of scientific research. Annissa started their career in 2007 as a Graduate Student Researcher at Wake Forest Baptist Health, where they focused on biophysical and structural studies. Annissa then moved on to work as a Research Fellow at Dana-Farber Cancer Institute, gaining further experience in the lab of Loren Walensky. In 2016, Annissa joined Constellation Pharmaceuticals as a Scientist I, eventually progressing to Scientist II. Annissa'smost recent role was at Kymera Therapeutics, where they held positions as a Senior Scientist and currently as a Principal Scientist. The precise details of their roles and responsibilities within each company are not provided.

Annissa Huhn obtained a BA degree in Biochemistry, History, and Music from DePauw University, where they studied from 2003 to 2007. Annissa then pursued a Ph.D. in Biochemistry and Molecular Biology at Wake Forest University School of Medicine, completing their studies from 2007 to 2012.